Steroid Depleted Processed Serum

Added to your cart

Steroid Depleted Processed Serum

Cart subtotal: £0.00

View cart (0) Checkout

#SKU SF236-7


Price excludes shipping costs.
To view our shipping costs click here.

Not all of our products can be shipped to all countries. If you're experiencing issues, please contact our customer service team.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

Pooled normal human plasma is processed by defibrinantion to prepare a processed serum which is further depleted of the steroid sex hormones. Processed serum is filtered to 0.2µm for optimal product clarity. The total and free levels of Cortisol, Progesterone, Testosterone and Estridiol are measured on the Roche Modular system.

More information



  • Shipping Information
  • Dry Ice
  • Abbreviations
  • Sex hormone depl. processed serum
  • Specification
  • < 0.5 nmol/L Progesterone, < 0.12 nmol/L Estradiol, < 0.4 nmol/L Testosterone, < 20 nmol/L Cortisol
  • Recommended Use
  • Research and further manufacturing
  • Preservatives
  • N/A
  • Buffer
  • N/A
  • Disease Area
  • Hormones
  • Presentation Matrix
  • steroid depleted frozen liquid processed serum, filtered through 0.2µm membrane
  • Source
  • human plasma
  • Applications
  • For Research and further manufacturing

Technical Documents

Certificates Of Analysis (75.9KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox